IL139491A0 - Phthalazine derivatives as phosphodiesterase-4 inhibitors - Google Patents
Phthalazine derivatives as phosphodiesterase-4 inhibitorsInfo
- Publication number
- IL139491A0 IL139491A0 IL13949199A IL13949199A IL139491A0 IL 139491 A0 IL139491 A0 IL 139491A0 IL 13949199 A IL13949199 A IL 13949199A IL 13949199 A IL13949199 A IL 13949199A IL 139491 A0 IL139491 A0 IL 139491A0
- Authority
- IL
- Israel
- Prior art keywords
- phosphodiesterase
- inhibitors
- phthalazine derivatives
- phthalazine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98MI001671A ITMI981671A1 (it) | 1998-07-21 | 1998-07-21 | Derivati ftalazinici inibitori della fosfodisterasi 4 |
| PCT/EP1999/005068 WO2000005219A1 (en) | 1998-07-21 | 1999-07-16 | Phthalazine derivatives as phosphodiesterase 4 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL139491A0 true IL139491A0 (en) | 2001-11-25 |
Family
ID=11380475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13949199A IL139491A0 (en) | 1998-07-21 | 1999-07-16 | Phthalazine derivatives as phosphodiesterase-4 inhibitors |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6340684B1 (xx) |
| EP (1) | EP1098886A1 (xx) |
| JP (1) | JP2002521371A (xx) |
| AU (1) | AU766076B2 (xx) |
| CA (1) | CA2337954A1 (xx) |
| CZ (1) | CZ2001240A3 (xx) |
| EA (1) | EA003702B1 (xx) |
| HU (1) | HUP0103349A3 (xx) |
| IL (1) | IL139491A0 (xx) |
| IT (1) | ITMI981671A1 (xx) |
| NZ (1) | NZ507930A (xx) |
| WO (1) | WO2000005219A1 (xx) |
| ZA (1) | ZA200006577B (xx) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1296984B1 (it) * | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| ITMI981671A1 (it) | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodisterasi 4 |
| DE19921567A1 (de) | 1999-05-11 | 2000-11-16 | Basf Ag | Verwendung von Phthalazine-Derivaten |
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| DE19963607B4 (de) * | 1999-12-23 | 2005-12-15 | Schering Ag | Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen |
| ITMI20000261A1 (it) | 2000-02-16 | 2001-08-16 | Zambon Group | Processo per la preparazione di piridiniliden-ftalidi |
| US7151102B2 (en) * | 2000-10-30 | 2006-12-19 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
| US7196085B2 (en) | 2002-04-30 | 2007-03-27 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
| GB0305681D0 (en) | 2003-03-12 | 2003-04-16 | Kudos Pharm Ltd | Phthalazinone derivatives |
| US7449464B2 (en) | 2003-03-12 | 2008-11-11 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
| EP1745039A4 (en) * | 2004-05-08 | 2009-07-22 | Neurogen Corp | 3-ARYL-5,6-DISUBSTITUTED PYRIDAZINES |
| ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
| GB0419072D0 (en) | 2004-08-26 | 2004-09-29 | Kudos Pharm Ltd | Phthalazinone derivatives |
| AU2005282721A1 (en) * | 2004-09-03 | 2006-03-16 | Memory Pharmaceuticals Corporation | 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| AR050948A1 (es) | 2004-09-24 | 2006-12-06 | Hoffmann La Roche | Derivados de ftalazinona; su obtencion y su utilizacion en la fabricacion de medicamentos para el tratamiento del cancer. |
| GB0428111D0 (en) * | 2004-12-22 | 2005-01-26 | Kudos Pharm Ltd | Pthalazinone derivatives |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| GB0521373D0 (en) | 2005-10-20 | 2005-11-30 | Kudos Pharm Ltd | Pthalazinone derivatives |
| EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| EP1991531A1 (en) * | 2006-02-28 | 2008-11-19 | Amgen Inc. | Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| CN101500997A (zh) * | 2006-06-15 | 2009-08-05 | 库多斯药物有限公司 | Parp抑制剂 |
| JP2009539962A (ja) * | 2006-06-15 | 2009-11-19 | クドス ファーマシューティカルズ リミテッド | Ｐａｒｐ阻害剤としての２−オキシヘテロアリールアミド誘導体 |
| CN101484421A (zh) * | 2006-06-15 | 2009-07-15 | 库多斯药物有限公司 | 作为parp抑制剂的2-氧基苯甲酰胺衍生物 |
| MX2009002496A (es) | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20080280910A1 (en) * | 2007-03-22 | 2008-11-13 | Keith Allan Menear | Phthalazinone derivatives |
| TW200900396A (en) * | 2007-04-10 | 2009-01-01 | Kudos Pharm Ltd | Phthalazinone derivatives |
| US20090023727A1 (en) * | 2007-07-05 | 2009-01-22 | Muhammad Hashim Javaid | Phthalazinone derivatives |
| US7981890B2 (en) | 2007-09-14 | 2011-07-19 | Astrazeneca Ab | Phthalazinone derivatives |
| BRPI0817537B1 (pt) * | 2007-10-17 | 2022-04-05 | Kudos Pharmaceuticals Limited | 4-[3-(4-ciclopropanocarbonil-piperazina-1-carbonil)-4-fluoro-benzil]-2h-ftalazin-1-ona, método para obtê-lo, composição farmacêutica compreendendo o mesmo, bem como usos terapêuticos do dito composto |
| UY31603A1 (es) | 2008-01-23 | 2009-08-31 | Derivados de ftalazinona | |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| HRP20161154T4 (hr) * | 2008-10-07 | 2023-09-29 | Kudos Pharmaceuticals Limited | Farmaceutska formulacija 514 |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| TW201114756A (en) * | 2009-07-15 | 2011-05-01 | Astrazeneca Ab | Phthalazinone compound |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| US9783529B2 (en) | 2013-03-13 | 2017-10-10 | Flatley Discovery Lab, Llc | Pyridazinone compounds and methods for the treatment of cystic fibrosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3274185A (en) * | 1963-10-08 | 1966-09-20 | S E Massengill Company | Phthalazine derivatives |
| GB2063249A (en) * | 1979-10-09 | 1981-06-03 | Mitsubishi Yuka Pharma | 4-Phenylphthalazine derivatives |
| US6207666B1 (en) * | 1995-06-07 | 2001-03-27 | Cell Pathways, Inc. | Method for treating a patient having precancerous lesion with 4-phenylphthalazine derivatives |
| DE69720515T2 (de) * | 1996-12-18 | 2004-02-19 | Neurogen Corp., Branford | Isoquinolinamin und phtalazinamin derivate, die reagieren mit crf rezeptoren |
| IT1296985B1 (it) | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati benzazinici inibitori della fosfodiesterasi 4 |
| IT1296984B1 (it) * | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| ITMI981670A1 (it) | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| ITMI981671A1 (it) | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodisterasi 4 |
-
1998
- 1998-07-21 IT IT98MI001671A patent/ITMI981671A1/it unknown
-
1999
- 1999-07-16 JP JP2000561175A patent/JP2002521371A/ja active Pending
- 1999-07-16 CA CA002337954A patent/CA2337954A1/en not_active Abandoned
- 1999-07-16 EP EP99932894A patent/EP1098886A1/en not_active Withdrawn
- 1999-07-16 EA EA200100061A patent/EA003702B1/ru not_active IP Right Cessation
- 1999-07-16 HU HU0103349A patent/HUP0103349A3/hu unknown
- 1999-07-16 NZ NZ507930A patent/NZ507930A/xx unknown
- 1999-07-16 IL IL13949199A patent/IL139491A0/xx unknown
- 1999-07-16 US US09/764,983 patent/US6340684B1/en not_active Expired - Fee Related
- 1999-07-16 WO PCT/EP1999/005068 patent/WO2000005219A1/en not_active Application Discontinuation
- 1999-07-16 CZ CZ2001240A patent/CZ2001240A3/cs unknown
- 1999-07-16 AU AU49116/99A patent/AU766076B2/en not_active Ceased
-
2000
- 2000-11-13 ZA ZA200006577A patent/ZA200006577B/xx unknown
-
2001
- 2001-11-14 US US09/987,266 patent/US6498160B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0103349A2 (hu) | 2002-02-28 |
| HUP0103349A3 (en) | 2003-01-28 |
| EA200100061A1 (ru) | 2001-08-27 |
| ZA200006577B (en) | 2002-04-24 |
| WO2000005219A1 (en) | 2000-02-03 |
| EA003702B1 (ru) | 2003-08-28 |
| US20020058662A1 (en) | 2002-05-16 |
| ITMI981671A1 (it) | 2000-01-21 |
| EP1098886A1 (en) | 2001-05-16 |
| AU4911699A (en) | 2000-02-14 |
| CZ2001240A3 (cs) | 2001-09-12 |
| CA2337954A1 (en) | 2000-02-03 |
| US6498160B2 (en) | 2002-12-24 |
| NZ507930A (en) | 2002-11-26 |
| AU766076B2 (en) | 2003-10-09 |
| ITMI981671A0 (it) | 1998-07-21 |
| US6340684B1 (en) | 2002-01-22 |
| JP2002521371A (ja) | 2002-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL139491A0 (en) | Phthalazine derivatives as phosphodiesterase-4 inhibitors | |
| IL143782A0 (en) | Quinoline derivatives | |
| GB9900416D0 (en) | Inhibitors | |
| HK1036618A1 (en) | Quinoline derivatives | |
| PL345388A1 (en) | Quinoline derivatives | |
| GB9904103D0 (en) | Quinoline derivatives | |
| IL141445A0 (en) | Benzazine derivatives as phosphodiesterase 4 inhibitors | |
| HK1041407B (zh) | 作為環氧酶-2抑制劑的二芳基苯並吡喃衍生物 | |
| HUP0103634A3 (en) | Quinoline derivatives | |
| IL150114A0 (en) | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors | |
| EE200100039A (et) | Ftalasiinderivaadid kui fosfodiesteraas-4 inhibiitorid | |
| IL136885A0 (en) | 2,3-substituted indole compounds as cox-2 inhibitors | |
| PL354979A1 (en) | Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors | |
| IL141446A0 (en) | Benzazine derivatives as phosphodiesterase 4 inhibitors | |
| AU2608301A (en) | Methods for inhibiting mastocytosis | |
| EP1153022A4 (en) | PROTEASE INHIBITORS | |
| GB9917294D0 (en) | Inhibitors | |
| GB9929340D0 (en) | Inhibitors | |
| GB9929341D0 (en) | Inhibitors | |
| GB9900413D0 (en) | Inhibitors | |
| GB9904104D0 (en) | Quinoline derivatives | |
| GB9904102D0 (en) | Quinoline derivatives | |
| GB9904105D0 (en) | Quinoline derivatives | |
| SI1109560T1 (en) | Compounds useful as aicarft inhibitors | |
| ZA200203157B (en) | Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors. |